Intermune (ITMN) is halted, news pending. It&s probably related to Esbriet(R) (pirfenidone) for pulmonary fibrosis, which an FDA panel recommended approval of on Mar 9. A May 4 target date has been set under the PDUFA. ...
Intermune FDA Update. May 4th, 2010 by admin Leave a reply ». I have corresponded with the FDA via email, I will post it below, they didn&t give me any additional information. Good luck to longs, on a final note, the last time I ...
Intermune (ITMN) is halted, news pending. It&s probably related to Esbriet(R) (pirfenidone) for pulmonary fibrosis, which an FDA panel recommended approval of on Mar 9. A May 4 target date has been set under the PDUFA. ...
Intermune (ITMN) is halted, news pending. It&s probably related to Esbriet(R) (pirfenidone) for pulmonary fibrosis, which an FDA panel recommended approval of on Mar 9. A May 4 target date has been set under the PDUFA. ...
Specifically, the speculator bought to open 1000 contracts of InterMune&s June 65 call, and simultaneously sold to open 1000 contracts of the equity&s June 75 call. The trader shelled out $3.53 for each June 65 call, and raked in $1.48 ...
No comments:
Post a Comment